XM does not provide services to residents of the United States of America.

Scent and flavour maker Givaudan tops sales forecasts on strong demand



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Scent and flavour maker Givaudan tops sales forecasts on strong demand</title></head><body>

Adds analyst quotes in paragraphs 8-9, regional performance and outlook in paragraphs 10-11, shares in paragraph 12

By Jagoda Darlak and Matteo Allievi

Oct 10 (Reuters) -Swiss fragrance and flavour maker Givaudan GIVN.S reported third-quarter sales above expectations on Thursday driven by sustained high demand across its markets.

Givaudan's quarterly sales rose 10.2% to 1.91 billion Swiss francs ($2.22 billion) on a reported basis, ahead of analysts' average forecast of 1.86 billion francs in a poll compiled by the company.

While the rest of the European chemicals sector, and Germany in particular, is grappling with weak demand amid a sluggish economy, companies engaged in the fragrance and flavour markets have seen a strong increase in sales.

A wave of destocking amid softer demand hit Givaudan's volumes last year, but strong sales growth has boosted its profitability since then.

"We are able to continue to support the strong and broad based volume demand from our customers," CEO Gilles Andrier said in the statement.

On a like-for-like basis, Givaudan's sales rose 14.1% in the third quarter, above the 10.4% growth expected by analysts, and a third straight quarter of double-digit percentage growth.

Like-for-like sales at its Taste & Wellbeing business, which makes up more than half of Givaudan's revenue, rose 12.4% from a year earlier, while sales at the Fragrance & Beauty unit were up 16.0%.

"The highlight of Q3 is the acceleration in Taste which has been lagging the exceptionally strong Fragrance business for quite some time," Vontobel analyst Arben Hasanaj said.

Depending on how the consumer sentiment develops, next year should see a much more normalised environment, Hasanaj added.

Givaudan's January-September sales rose in all regions. The highest like-for-like increase was seen in Latin America at 29.5%, while North American sales grew 5.7% compared to a decline of 9.3% last year.

It reiterated the target for average organic sales growth of 4-5% per year until 2025, with free cash flow growth of at least 12%.

Givaudan's shares were up 0.8% by 0740 GMT, after spiking 4% earlier in the session.

($1 = 0.8604 Swiss francs)



Reporting by Jagoda Darlak and Matteo Allievi in Gdansk; editing by Milla Nissi

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.